Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX
· Real-Time Price · USD
5.08
-0.06 (-1.26%)
At close: Aug 15, 2025, 2:03 PM
Foghorn Therapeutics Revenue
Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending June 30, 2025, Foghorn Therapeutics generated $7.56M in revenue.
Revenue (ttm)
22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
201.8K
Employees
112
Market Cap
287.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|